Intensified multifactorial treatment of patients with Type 2 diabetes: what can be achieved and does it pay off?

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Intensified multifactorial treatment of patients with Type 2 diabetes : what can be achieved and does it pay off? / Pedersen, Oluf.

In: Journal of Diabetes, Vol. 1, No. 2, 2009, p. 83-9.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Pedersen, O 2009, 'Intensified multifactorial treatment of patients with Type 2 diabetes: what can be achieved and does it pay off?', Journal of Diabetes, vol. 1, no. 2, pp. 83-9. https://doi.org/10.1111/j.1753-0407.2009.00014.x

APA

Pedersen, O. (2009). Intensified multifactorial treatment of patients with Type 2 diabetes: what can be achieved and does it pay off? Journal of Diabetes, 1(2), 83-9. https://doi.org/10.1111/j.1753-0407.2009.00014.x

Vancouver

Pedersen O. Intensified multifactorial treatment of patients with Type 2 diabetes: what can be achieved and does it pay off? Journal of Diabetes. 2009;1(2):83-9. https://doi.org/10.1111/j.1753-0407.2009.00014.x

Author

Pedersen, Oluf. / Intensified multifactorial treatment of patients with Type 2 diabetes : what can be achieved and does it pay off?. In: Journal of Diabetes. 2009 ; Vol. 1, No. 2. pp. 83-9.

Bibtex

@article{21095f6d78e047d99603e28dd2962b5c,
title = "Intensified multifactorial treatment of patients with Type 2 diabetes: what can be achieved and does it pay off?",
abstract = "By influencing the standards of diabetes care and treatment guidelines throughout the world, the results of recent long-term risk factor interventions in Type 2 diabetes (T2D) have likely contributed to the improved health outcomes and induced a decline in mortality in people with T2D. Although we have a need for even more evidence to support early, individualized, and intensive management of all known modifiable risk factors, we have now reached an era in T2D care where the critical challenges appear to be to translate the insights, knowledge and benefits to patients in the community setting. Current surveys show slow progress in achieving treatment goals and in the use of recommended drugs and adjustments of lifestyle for the prevention of vascular complications in diabetes. The resistance and barriers among medical professionals and patients likely have multiple causes. The present review focuses on experiences from multifactorial interventions in high-risk patients with T2D where it is possible to markedly improve their prognosis.",
keywords = "Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Male, Patient Education as Topic, Risk Factors",
author = "Oluf Pedersen",
year = "2009",
doi = "10.1111/j.1753-0407.2009.00014.x",
language = "English",
volume = "1",
pages = "83--9",
journal = "Journal of Diabetes",
issn = "1753-0393",
publisher = "Wiley-Blackwell",
number = "2",

}

RIS

TY - JOUR

T1 - Intensified multifactorial treatment of patients with Type 2 diabetes

T2 - what can be achieved and does it pay off?

AU - Pedersen, Oluf

PY - 2009

Y1 - 2009

N2 - By influencing the standards of diabetes care and treatment guidelines throughout the world, the results of recent long-term risk factor interventions in Type 2 diabetes (T2D) have likely contributed to the improved health outcomes and induced a decline in mortality in people with T2D. Although we have a need for even more evidence to support early, individualized, and intensive management of all known modifiable risk factors, we have now reached an era in T2D care where the critical challenges appear to be to translate the insights, knowledge and benefits to patients in the community setting. Current surveys show slow progress in achieving treatment goals and in the use of recommended drugs and adjustments of lifestyle for the prevention of vascular complications in diabetes. The resistance and barriers among medical professionals and patients likely have multiple causes. The present review focuses on experiences from multifactorial interventions in high-risk patients with T2D where it is possible to markedly improve their prognosis.

AB - By influencing the standards of diabetes care and treatment guidelines throughout the world, the results of recent long-term risk factor interventions in Type 2 diabetes (T2D) have likely contributed to the improved health outcomes and induced a decline in mortality in people with T2D. Although we have a need for even more evidence to support early, individualized, and intensive management of all known modifiable risk factors, we have now reached an era in T2D care where the critical challenges appear to be to translate the insights, knowledge and benefits to patients in the community setting. Current surveys show slow progress in achieving treatment goals and in the use of recommended drugs and adjustments of lifestyle for the prevention of vascular complications in diabetes. The resistance and barriers among medical professionals and patients likely have multiple causes. The present review focuses on experiences from multifactorial interventions in high-risk patients with T2D where it is possible to markedly improve their prognosis.

KW - Cardiovascular Diseases

KW - Diabetes Mellitus, Type 2

KW - Humans

KW - Hypoglycemic Agents

KW - Male

KW - Patient Education as Topic

KW - Risk Factors

U2 - 10.1111/j.1753-0407.2009.00014.x

DO - 10.1111/j.1753-0407.2009.00014.x

M3 - Journal article

C2 - 20929504

VL - 1

SP - 83

EP - 89

JO - Journal of Diabetes

JF - Journal of Diabetes

SN - 1753-0393

IS - 2

ER -

ID: 38453680